These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29606398)

  • 1. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.
    Kraaij T; Kamerling SWA; van Dam LS; Bakker JA; Bajema IM; Page T; Brunini F; Pusey CD; Toes REM; Scherer HU; Rabelink TJ; van Kooten C; Teng YKO
    Kidney Int; 2018 Jul; 94(1):139-149. PubMed ID: 29606398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.
    Shida H; Hashimoto N; Kusunoki Y; Hattanda F; Ogawa Y; Hayashi T; Nakazawa D; Masuda S; Tomaru U; Ishizu A
    BMC Nephrol; 2018 Jun; 19(1):145. PubMed ID: 29929470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
    Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
    Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
    Söderberg D; Kurz T; Motamedi A; Hellmark T; Eriksson P; Segelmark M
    Rheumatology (Oxford); 2015 Nov; 54(11):2085-94. PubMed ID: 26170375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Masuda S; Nonokawa M; Futamata E; Nishibata Y; Iwasaki S; Tsuji T; Hatanaka Y; Nakazawa D; Tanaka S; Tomaru U; Kawakami T; Atsumi T; Ishizu A
    Am J Pathol; 2019 Apr; 189(4):839-846. PubMed ID: 30677396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.
    Söderberg D; Segelmark M
    Front Immunol; 2016; 7():256. PubMed ID: 27446086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection by flow cytometry of anti-neutrophil cytoplasmic antibodies in a novel approach based on neutrophil extracellular traps.
    Roitsch S; Gößwein S; Neurath MF; Leppkes M
    Autoimmunity; 2018 Sep; 51(6):288-296. PubMed ID: 30994385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The net effect of ANCA on neutrophil extracellular trap formation.
    Heeringa P; Rutgers A; Kallenberg CGM
    Kidney Int; 2018 Jul; 94(1):14-16. PubMed ID: 29933842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis.
    Tang S; Zhang Y; Yin SW; Gao XJ; Shi WW; Wang Y; Huang X; Wang L; Zou LY; Zhao JH; Huang YJ; Shan LY; Gounni AS; Wu YZ; Zhang JB
    Clin Exp Immunol; 2015 Jun; 180(3):408-18. PubMed ID: 25644394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Compared to Systemic Lupus Erythematosus.
    van Dam LS; Kraaij T; Kamerling SWA; Bakker JA; Scherer UH; Rabelink TJ; van Kooten C; Teng YKO
    Arthritis Rheumatol; 2019 Dec; 71(12):2047-2058. PubMed ID: 31313503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
    Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of anti-neutrophil extracellular trap antibody in patients with microscopic polyangiitis.
    Hattanda F; Nakazawa D; Watanabe-Kusunoki K; Kusunoki Y; Shida H; Masuda S; Nishio S; Tomaru U; Atsumi T; Ishizu A
    Rheumatology (Oxford); 2019 Jul; 58(7):1293-1298. PubMed ID: 30897615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
    Berglin E; Mohammad AJ; Dahlqvist J; Johansson L; Eriksson C; Sjöwall J; Rantapää-Dahlqvist S
    J Autoimmun; 2021 Feb; 117():102579. PubMed ID: 33340843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil extracellular traps can activate alternative complement pathways.
    Wang H; Wang C; Zhao MH; Chen M
    Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.
    Flint SM; McKinney EF; Smith KG
    Curr Opin Rheumatol; 2015 Mar; 27(2):197-203. PubMed ID: 25629443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis.
    Takeda S; Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Nishio S; Atsumi T
    Front Immunol; 2019; 10():1334. PubMed ID: 31249574
    [No Abstract]   [Full Text] [Related]  

  • 18. The involvement of NETs in ANCA-associated vasculitis.
    Shiratori-Aso S; Nakazawa D
    Front Immunol; 2023; 14():1261151. PubMed ID: 37781373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis.
    Ueda Y; Nakazawa D; Nishio S; Shiratori-Aso S; Kudo T; Miyoshi-Harashima A; Watanabe-Kusunoki K; Hattanda F; Iwasaki S; Tsuji T; Tomaru U; Aratani Y; Yamamoto M; Ishizu A; Atsumi T
    Kidney Int; 2024 Jun; 105(6):1291-1305. PubMed ID: 38537677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
    Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.